Investigating Novel Genetic Markers for Fluoroquinolone Associated Disorders

Andrew Bennett1

  • 1SONAR (Southern Network on Adverse Reactions) Program, University of South Carolina College of Pharmacy, Columbia, SC, 29208, USA. andrew.bennett@pharm.ox.ac.uk.

Insights

Fluoroquinolones are widely used antibiotics approved for treating infections like anthrax and pneumonia. This summary highlights their common applications in medicine.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Fluoroquinolones (FQs) represent a significant class of frequently prescribed antibiotics.
  • These antimicrobial agents possess broad-spectrum activity against various bacterial pathogens.

Purpose of the Study:

  • To outline the established therapeutic applications of fluoroquinolones.
  • To underscore the regulatory approval status for key indications.

Main Methods:

  • Review of existing literature on fluoroquinolone usage.
  • Analysis of regulatory documentation for approved indications.

Main Results:

  • Fluoroquinolones are approved for treating anthrax, pneumonia, urinary tract infections, and sinus infections.
  • Their efficacy is recognized for a range of bacterial infections.

Conclusions:

  • Fluoroquinolones are a cornerstone in treating several serious bacterial infections.
  • Their established safety and efficacy support their continued widespread clinical use.